Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to look at the long term effects of a complex socio-affective mental training program on a neuroscientific-, hormonal-, behavioral-, biological, and subjective measures-level. The training protocol consists of a variety of meditation and other mental health techniques, which are trained over the period of 3-9 months (13 weeks per Module; 1-3 Modules)


Clinical Trial Description

The ReSource Project is a unique, large-scale study on the effects of mental training techniques. Over a period of three to nine months, participants practice a wide range of mental exercises that are designed to enhance attentional control, body- and self-awareness, emotion regulation, self-care, compassion, empathy, and perspective taking. Overall, the aim of the training is to improve mental health and social skills. It may reduce stress, improve mental clarity, increase life satisfaction, and lead to a better understanding of others' views, values, and actions.

The ReSource Project is a secular program developed by a team of experienced meditation teachers, scientists, and psychotherapists.

Over the last decades, isolation, stress, and psychological tensions have been steadily increasing in our society. Mental training can alter stress responses, physical health, resilience, attention, perception, emotional experience, and social behavior. Evidence for these results is based on previous studies showing behavioral changes, as well as observed changes in brain function and structure. Moreover, health factors, such as peripheral autonomic responses, stress hormones, and immune parameters were significantly changed after training.

The ReSource Project consists of three consecutive modules: called "Presence", "Perspective", and "Affect". The Presence Module trains mindful attention to internal mental and physical processes. The Perspective Module focuses on socio-cognitive abilities, such as insight into the nature of the mind and self, and also the ability to assume the perspective of others. The Affect Module focuses on constructive ways of dealing with difficult emotions, and works to cultivate prosocial motivations and positive emotions such as compassion.

In contrast to most previous studies of just a few months, the ReSource Project will be conducted over a period of 3-9 months for three experimental cohorts (cohorts start in a shifted design; 2 cohorts train over a period of 9 months (all 3 Modules in different orders, 13 weeks per Module), 1 cohort trains over 3 months (only the Affect Module)), and will cover a wide range of practices intended to enhance cognitive and socio-affective skills. 2 retest control cohorts account for the effects of repeated testing. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT01833104
Study type Interventional
Source Max Planck Institute for Human Cognitive and Brain Sciences
Contact
Status Completed
Phase N/A
Start date January 2013
Completion date February 2016

See also
  Status Clinical Trial Phase
Completed NCT05483998 - A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants Phase 1
Recruiting NCT02417714 - Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Recruiting NCT02235012 - Cognitive Biases Under Ketamine N/A
Completed NCT05088343 - Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects Phase 1
Completed NCT04418973 - Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject. N/A
Not yet recruiting NCT06248801 - Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets Phase 1
Terminated NCT04068259 - Single Ascending Dose Study of PBI-4547 in Healthy Subjects Phase 1
Completed NCT03279302 - Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects Phase 1
Not yet recruiting NCT06233162 - Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets Phase 1
Recruiting NCT04159844 - Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects N/A
Completed NCT06137911 - Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults. Phase 1
Completed NCT04849286 - Measurement of HTL0016878 in Cerebrospinal Fluid Phase 1
Not yet recruiting NCT06233227 - Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule Phase 1
Completed NCT04096157 - A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants Phase 1
Completed NCT01200368 - Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants Phase 3
Recruiting NCT05805033 - Peri-Implant Soft Tissue Integration in Humans: Influence of Material N/A
Completed NCT04027803 - Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris® Phase 1
Recruiting NCT03467880 - Multicenter Study of Impulse Oscillometry in Chinese N/A
Completed NCT02903095 - Single Ascending Dose Study of TD-1439 in Healthy Subjects Phase 1
Active, not recruiting NCT02341508 - A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers Phase 1